Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
North American Niobium Receives Key Seigneurie Authorization
-
Purpose Investments Inc. Announces Final March 2026 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund
-
Plus Therapeutics Appoints Diagnostics and Molecular Diagnostics Industry Leader Ron Andrews to its Board of Directors
-
Bridger Aerospace Names Justin Mogford as General Counsel, Further Strengthening Management Team
-
Local news returns to print: Metroland and Torstar launch monthly print newspapers across Greater Toronto Area
-
SAGA Metals Acquires Strategic Titanium Assets from Rio Tinto in Quebec
-
Avicanna Subsidiary SMGH Completes First Commercial Export to Australia
-
Mustang Confirms and Expands Large IP Geophysical Anomaly at the Pilot Cu-Au Project, Provides Update on General Exploration Activities in Nevada, USA
-
Xtract One Selected by University of Michigan Health-West to Strengthen Emergency Department Security
-
Hillman Recognized by REDI Cincinnati with James A. Wuenker Growth Award for Forest Fair Mall Redevelopment Project
-
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
-
Dynacor: Strong Fourth Quarter Caps Record Financial Performance and Expanded Growth Pipeline in 2025
-
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
-
Transglobal Management Group, Inc. (TMGI) Strengthens Leadership and Board in Preparation for Uplisting
-
Abaxx Announces Fourth Quarter and Year-End 2025 Earnings and Business Update Call
-
Wave Life Sciences Announces Positive Interim Phase 1 Data from INLIGHT: Further Improvements in Body Composition, with Clinically Meaningful Reductions in Visceral Fat and Waist Circumference, at Six
-
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
-
Bombardier Celebrates First Delivery of the Global 8000 Aircraft to Esteemed Customer NetJets
-
GlobalTech Corporation Approved for Quotation on OTCQB Venture Market, Advancing Capital Markets Strategy
-
Luana Savings Bank Selects nCino to Unify and Transform Its Commercial and Agricultural Lending Operations
-
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
-
RVYL Shareholder Meeting Continued to April 1, with 99% of Votes Cast in Favor of Roundtable Merger
-
SPIE announces the winners of Innovation Day 2026
-
New study identifies shared mathematical principle linking how cells, companies, and cities diversify
-
Cielo Provides Update on Proposed Acquisition and Announces Investor Summit Presentation
-
Labrador Gold Welcomes Recent Announcement by the Ontario Government Concerning Accelerated Development of the Ring of Fire Road
-
StorageVault Expands Footprint with Completion of $62.5 Million of Acquisitions of Five Storage Assets
-
VR Completes Bonding Process for NOI Drill Permit for its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada
-
Verde AgriTech Announces Q4 & FY 2025 Earnings Results
-
ValOre Reports Positive Leaching Results from Ongoing Metallurgical Program for Pedra Branca PGM Project, Brazil; 73% Platinum and 74% Palladium Achieved Extraction from Weathered Material and 66% Pla
-
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
-
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
-
First Quantum Provides Notice of First Quarter 2026 Results
-
The Lovesac Company Expands Share Repurchase Authorization by $40 Million
-
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
-
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine
-
Dmitry Shubov Discusses the "Agentic Shift" in Southeast Asia’s 2026 Legal-Tech Market
-
Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
-
First Quantum Minerals Provides Notice of Annual General Meeting of Shareholders and Filing of Management Information Circular and Supporting Documents
-
USA Rare Earth Achieves Major Operational and Strategic Milestone with Commissioning of Phase 1a Magnet Production at Stillwater Facility
-
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2025 and Provides Corporate Update
-
Abaxx Futures Now Available Through TMX Trayport’s Joule Platform
-
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
-
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
-
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
The Lovesac Company Reports Fourth Quarter and Fiscal 2026 Financial Results
-
Sportradar Expands Partnership with Hard Rock Bet, Adding Official Data from the PGA TOUR and Ultimate Fighting Championship
-
ADW Capital Management Sends Letter to Driven Brands Board and Controlling Shareholder Roark Capital Calling on the Company to Immediately Undertake a Strategic Review Process
-
Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit
-
Dmitry Shubov Discusses the "Agentic Shift" in Southeast Asia’s 2026 Legal-Tech Market
